|
시장보고서
상품코드
1786878
바이오서저리 시장 : 규모, 점유율, 동향, 산업 분석 보고서 - 제품별, 용도별, 지역별, 시장 예측(2025-2034년)Biosurgery Market Size, Share, Trends, Industry Analysis Report By Product (Surgical Sealants, Hemostatic Agents, Adhesion Barriers, Soft Tissue Attachments, Bone Graft Attachments, Others), By Application, By Region - Market Forecast, 2025-2034 |
||||||
Polaris Market Research의 최신 조사에 따르면 바이오서저리 시장 규모는 2034년까지 410억 달러에 이를 것으로 예측됩니다. 이 보고서는 현재 시장 역학을 상세하게 파악하고 미래 시장 성장에 대한 분석을 제공합니다.
바이오서저리는 수술을 지원하기 위해 천연 생물학적 생물 및 물질을 이용하여 치유를 촉진하고 합병증을 최소화하는 전문 의료 분야입니다. 외과의사는 구더기에 의한 데브리드만, 힐, 효소 및 기타 생물학적 약제를 이용하여 상처의 치료, 사 조직의 제거, 혈류의 개선을 실시합니다. 이러한 방법은 전통적인 수술을 대체하는 침습적 방법이며, 건강상의 위험으로 기존 수술을 받을 수 없는 환자에게 유용합니다.
바이오서저리는 기존의 수술에 비해 감염률이 낮고 흉터가 남기 어려우며 회복이 빠르다는 장점이 있습니다. 또한 면역력이 저하된 환자와 마취 합병증의 위험이 높은 환자에게도 장점이 있습니다. 그러나 특정 생물학적 약물에 알레르기 반응과 심리적 불편을 느끼는 사람도 있기 때문에 시술자는 신중하게 후보자를 선택해야 합니다.
바이오서저리 시장 보고서 하이라이트
제품별로 외과 수술용 실란트 부문은 2024년 28.38%의 매출 점유율을 차지했습니다. 이는 심혈관, 폐, 간 수술 등 폭넓은 수술 전문 분야에서의 사용이 증가하고 있기 때문입니다.
제품별로 연조직 부착 분야는 스포츠 부상 사례의 급증, 정형외과적 재건, 연조직 수복 처치로 인해 향후 수년간 견조한 페이스로 성장할 것으로 예측되고 있습니다.
용도별로는 효과적인 출혈 컨트롤과 조직 밀봉을 필요로 하는 복부, 소화관, 간담췌 처리의 보급이 진행되고 있기 때문에 일반외과가 2024년의 수익 시장 점유율을 독점했습니다.
심장혈관 외과 분야는 심장 질환 유병률 증가, 개심술 및 혈관 수술 증가로 향후 수년간 빠르게 성장할 것으로 예측됩니다.
북미는 2024년 세계의 바이오서저리 시장에서 51.16%의 점유율을 차지했습니다. 이 이점은 만성 질환의 유병률 증가 및 고령화로 인한 것입니다.
미국은 2024년 북미 바이오서저리 시장 점유율의 77.79%를 차지했는데, 이는 높은 헬스케어 지출 및 저침습 절차에 대한 강한 주목으로 인한 것입니다.
아시아태평양 시장은 헬스케어 인프라의 급속한 개선 및 수술 증가로 향후 수년간 견조한 속도로 성장할 것으로 예측됩니다.
인도 시장은 첨단 상처 케어 및 수술용 지혈재에 대한 의식이 높아짐에 따라 확대되고 있습니다.
유럽 시장은 확립된 헬스케어 시스템 및 수술 건수가 많기 때문에 2034년에는 상당한 시장 점유율을 차지할 것으로 예측되고 있습니다.
세계 주요 시장 기업은 Artivion, Inc., Aroa Biosurgery, B. Braun SE, Baxter, BD, INTEGRA LIFESCIENCES, Johnson & Johnson Services, Inc., Medtronic, Pfizer Inc., Sanofi, Stryker 등이 있습니다.
목차
제1장 서론
제2장 주요 요약
제3장 조사 방법
제4장 세계의 바이오서저리 시장 인사이트
- 시장 현황
- 바이오서저리 시장 역학
- 성장 촉진요인 및 기회
- 저침습 수술 수요 증가
- 만성 질환 증가
- 성장 억제요인 및 과제
- 고비용
- 성장 촉진요인 및 기회
- PESTEL 분석
- 바이오서저리 시장 동향
- 밸류체인 분석
- COVID-19의 영향 분석
제5장 세계의 바이오서저리 시장 : 제품별
- 주요 조사 결과
- 서문
- 외과 수술용 실란트
- 지혈제
- 유착 방지 장벽
- 연부 조직 부착부
- 뼈 이식 부착
- 기타
제6장 세계의 바이오서저리 시장 : 용도별
- 주요 조사 결과
- 서문
- 일반 외과
- 정형외과
- 심장혈관 수술
- 신경외과
- 기타
제7장 세계의 바이오서저리 시장 : 지역별
- 주요 조사 결과
- 서문
- 바이오서저리 시장 평가 : 지역별(2020-2034년)
- 북미
- 북미 : 제품별(2020-2034년)
- 북미 : 용도별(2020-2034년)
- 미국
- 캐나다
- 유럽
- 유럽 : 제품별(2020-2034년)
- 유럽 : 용도별(2020-2034년)
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
- 아시아태평양
- 아시아태평양 : 제품별(2020-2034년)
- 아시아태평양 : 용도별(2020-2034년)
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
- 중동 및 아프리카
- 중동 및 아프리카 : 제품별(2020-2034년)
- 중동 및 아프리카 : 용도별(2020-2034년)
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 남아프리카
- 기타 중동 및 아프리카
- 라틴아메리카
- 라틴아메리카 : 제품별(2020-2034년)
- 라틴아메리카 : 용도별(2020-2034년)
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카
제8장 경쟁 구도
- 확대 및 인수 분석
- 확대
- 인수
- 제휴, 협업, 합의 및 공개
제9장 기업 프로파일
- Artivion, Inc.
- Aroa Biosurgery
- B. Braun SE
- Baxter
- BD
- INTEGRA LIFESCIENCES
- Johnson & Johnson Services, Inc.
- Medtronic
- Sanofi
- Pfizer Inc.
- Stryker
The biosurgery market size is expected to reach USD 41.00 billion by 2034, according to a new study by Polaris Market Research. The report "Biosurgery Market Share, Size, Trends, Industry Analysis Report By Product (Surgical Sealants, Hemostatic Agents, Adhesion Barriers, Soft Tissue Attachments, Bone Graft Attachments, Others), By Application, By Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Biosurgery is a specialized medical field that utilizes natural biological organisms or substances to support surgical procedures, thereby promoting healing and minimizing complications. Surgeons employ maggot debridement, leeches, enzymes, or other biological agents to treat wounds, remove dead tissue, or improve blood flow. These methods offer a minimally invasive alternative to traditional surgery, benefiting patients who cannot undergo conventional procedures due to health risks.
Biosurgery offers several advantages, including lower infection rates, reduced scarring, and faster recovery times compared to conventional surgery. It also benefits patients with compromised immune systems or those at high risk for anesthesia complications. However, practitioners must carefully select candidates, as some individuals may experience allergic reactions or psychological discomfort with certain biological agents.
Biosurgery Market Report Highlights
In terms of product, the surgical sealants segment accounted for 28.38% revenue share in 2024 due to their increasing use across a wide range of surgical specialties, including cardiovascular, pulmonary, and hepatic procedures.
The soft tissue attachments segment, based on product, is projected to grow at a robust pace in the coming years, owing to the surge in the number of sports injury cases, orthopedic reconstructions, and soft tissue repair procedures.
Based on application, the general surgery dominated the revenue market share in 2024 due to the rising penetration of abdominal, gastrointestinal, and hepatobiliary procedures that require effective bleeding control and tissue sealing.
The cardiovascular surgery segment, in terms of application, is projected to grow at a rapid pace in the coming years, driven by the increasing prevalence of heart diseases and the rising number of open-heart and vascular procedures.
North America accounted for 51.16% share of the global biosurgery market in 2024. This dominance is attributed to the growing prevalence of chronic diseases and an aging population.
The U.S. held 77.79% of the North America biosurgery market share in 2024 due to high healthcare spending and a strong focus on minimally invasive procedures.
The market in Asia Pacific is projected to grow at a robust pace in the coming years, owing to the rapidly improving healthcare infrastructure and increasing surgical procedures.
The market in India is expanding due to rising awareness of advanced wound care and surgical hemostats.
The market in Europe is projected to hold a substantial market share in 2034 due to established healthcare systems and high surgical volumes.
A few global key market players include Artivion, Inc.; Aroa Biosurgery; B. Braun SE; Baxter; BD; INTEGRA LIFESCIENCES; Johnson & Johnson Services, Inc.; Medtronic; Pfizer Inc.; Sanofi; and Stryker.
Polaris Market Research has segmented the biosurgery market report on the basis of product, application, and region:
By Product Outlook (Revenue, USD Billion, 2020-2034)
Surgical Sealants
Hemostatic Agents
Adhesion Barriers
Soft Tissue Attachments
Bone Graft Attachments
Others
By Application Outlook (Revenue, USD Billion, 2020-2034)
General Surgery
Orthopedic Surgery
Cardiovascular Surgery
Neurological Surgery
Others
By Regional Outlook (Revenue, USD Billion, 2020-2034)
North America
U.S.
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Biosurgery Market Insights
- 4.1. Biosurgery Market - Market Snapshot
- 4.2. Biosurgery Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increasing Demand for Minimally Invasive Surgical Procedures
- 4.2.1.2. Growing Prevalence of Chronic Diseases
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High cost
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Biosurgery Market Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Biosurgery Market, by Product
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Biosurgery Market, by Product, 2020-2034 (USD Billion)
- 5.3. Surgical Sealants
- 5.3.1. Global Biosurgery Market, by Surgical Sealants, by Region, 2020-2034 (USD Billion)
- 5.4. Hemostatic Agents
- 5.4.1. Global Biosurgery Market, by Hemostatic Agents, by Region, 2020-2034 (USD Billion)
- 5.5. Adhesion Barriers
- 5.5.1. Global Biosurgery Market, by Adhesion Barriers, by Region, 2020-2034 (USD Billion)
- 5.6. Soft Tissue Attachments
- 5.6.1. Global Biosurgery Market, by Soft Tissue Attachments, by Region, 2020-2034 (USD Billion)
- 5.7. Bone Graft Attachments
- 5.7.1. Global Biosurgery Market, by Bone Graft Attachments, by Region, 2020-2034 (USD Billion)
- 5.8. Others
- 5.8.1. Global Biosurgery Market, by Others, by Region, 2020-2034 (USD Billion)
6. Global Biosurgery Market, by Application
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Biosurgery Market, by Application, 2020-2034 (USD Billion)
- 6.3. General Surgery
- 6.3.1. Global Biosurgery Market, by General Surgery, by Region, 2020-2034 (USD Billion)
- 6.4. Orthopedic Surgery
- 6.4.1. Global Biosurgery Market, by Orthopedic Surgery, by Region, 2020-2034 (USD Billion)
- 6.5. Cardiovascular Surgery
- 6.5.1. Global Biosurgery Market, by Cardiovascular Surgery, by Region, 2020-2034 (USD Billion)
- 6.6. Neurological Surgery
- 6.6.1. Global Biosurgery Market, by Neurological Surgery, by Region, 2020-2034 (USD Billion)
- 6.7. Others
- 6.7.1. Global Biosurgery Market, by Others, by Region, 2020-2034 (USD Billion)
7. Global Biosurgery Market, by Geography
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Biosurgery Market Assessment, By Geography, 2020-2034 (USD Billion)
- 7.3. Biosurgery Market - North America
- 7.3.1. North America: Biosurgery Market, by Product, 2020-2034 (USD Billion)
- 7.3.2. North America: Biosurgery Market, by Application, 2020-2034 (USD Billion)
- 7.3.3. Biosurgery Market - U.S.
- 7.3.3.1. U.S.: Biosurgery Market, by Product, 2020-2034 (USD Billion)
- 7.3.3.2. U.S.: Biosurgery Market, by Application, 2020-2034 (USD Billion)
- 7.3.4. Biosurgery Market - Canada
- 7.3.4.1. Canada: Biosurgery Market, by Product, 2020-2034 (USD Billion)
- 7.3.4.2. Canada: Biosurgery Market, by Application, 2020-2034 (USD Billion)
- 7.4. Biosurgery Market - Europe
- 7.4.1. Europe: Biosurgery Market, by Product, 2020-2034 (USD Billion)
- 7.4.2. Europe: Biosurgery Market, by Application, 2020-2034 (USD Billion)
- 7.4.3. Biosurgery Market - UK
- 7.4.3.1. UK: Biosurgery Market, by Product, 2020-2034 (USD Billion)
- 7.4.3.2. UK: Biosurgery Market, by Application, 2020-2034 (USD Billion)
- 7.4.4. Biosurgery Market - France
- 7.4.4.1. France: Biosurgery Market, by Product, 2020-2034 (USD Billion)
- 7.4.4.2. France: Biosurgery Market, by Application, 2020-2034 (USD Billion)
- 7.4.5. Biosurgery Market - Germany
- 7.4.5.1. Germany: Biosurgery Market, by Product, 2020-2034 (USD Billion)
- 7.4.5.2. Germany: Biosurgery Market, by Application, 2020-2034 (USD Billion)
- 7.4.6. Biosurgery Market - Italy
- 7.4.6.1. Italy: Biosurgery Market, by Product, 2020-2034 (USD Billion)
- 7.4.6.2. Italy: Biosurgery Market, by Application, 2020-2034 (USD Billion)
- 7.4.7. Biosurgery Market - Spain
- 7.4.7.1. Spain: Biosurgery Market, by Product, 2020-2034 (USD Billion)
- 7.4.7.2. Spain: Biosurgery Market, by Application, 2020-2034 (USD Billion)
- 7.4.8. Biosurgery Market - Netherlands
- 7.4.8.1. Netherlands: Biosurgery Market, by Product, 2020-2034 (USD Billion)
- 7.4.8.2. Netherlands: Biosurgery Market, by Application, 2020-2034 (USD Billion)
- 7.4.9. Biosurgery Market - Russia
- 7.4.9.1. Russia: Biosurgery Market, by Product, 2020-2034 (USD Billion)
- 7.4.9.2. Russia: Biosurgery Market, by Application, 2020-2034 (USD Billion)
- 7.4.10. Biosurgery Market - Rest of Europe
- 7.4.10.1. Rest of Europe: Biosurgery Market, by Product, 2020-2034 (USD Billion)
- 7.4.10.2. Rest of Europe: Biosurgery Market, by Application, 2020-2034 (USD Billion)
- 7.5. Biosurgery Market - Asia Pacific
- 7.5.1. Asia Pacific: Biosurgery Market, by Product, 2020-2034 (USD Billion)
- 7.5.2. Asia Pacific: Biosurgery Market, by Application, 2020-2034 (USD Billion)
- 7.5.3. Biosurgery Market - China
- 7.5.3.1. China: Biosurgery Market, by Product, 2020-2034 (USD Billion)
- 7.5.3.2. China: Biosurgery Market, by Application, 2020-2034 (USD Billion)
- 7.5.4. Biosurgery Market - India
- 7.5.4.1. India: Biosurgery Market, by Product, 2020-2034 (USD Billion)
- 7.5.4.2. India: Biosurgery Market, by Application, 2020-2034 (USD Billion)
- 7.5.5. Biosurgery Market - Malaysia
- 7.5.5.1. Malaysia: Biosurgery Market, by Product, 2020-2034 (USD Billion)
- 7.5.5.2. Malaysia: Biosurgery Market, by Application, 2020-2034 (USD Billion)
- 7.5.6. Biosurgery Market - Japan
- 7.5.6.1. Japan: Biosurgery Market, by Product, 2020-2034 (USD Billion)
- 7.5.6.2. Japan: Biosurgery Market, by Application, 2020-2034 (USD Billion)
- 7.5.7. Biosurgery Market - Indonesia
- 7.5.7.1. Indonesia: Biosurgery Market, by Product, 2020-2034 (USD Billion)
- 7.5.7.2. Indonesia: Biosurgery Market, by Application, 2020-2034 (USD Billion)
- 7.5.8. Biosurgery Market - South Korea
- 7.5.8.1. South Korea: Biosurgery Market, by Product, 2020-2034 (USD Billion)
- 7.5.8.2. South Korea: Biosurgery Market, by Application, 2020-2034 (USD Billion)
- 7.5.9. Biosurgery Market - Australia
- 7.5.9.1. Australia: Biosurgery Market, by Product, 2020-2034 (USD Billion)
- 7.5.9.2. Australia: Biosurgery Market, by Application, 2020-2034 (USD Billion)
- 7.5.10. Biosurgery Market - Rest of Asia Pacific
- 7.5.10.1. Rest of Asia Pacific: Biosurgery Market, by Product, 2020-2034 (USD Billion)
- 7.5.10.2. Rest of Asia Pacific: Biosurgery Market, by Application, 2020-2034 (USD Billion)
- 7.6. Biosurgery Market - Middle East & Africa
- 7.6.1. Middle East & Africa: Biosurgery Market, by Product, 2020-2034 (USD Billion)
- 7.6.2. Middle East & Africa: Biosurgery Market, by Application, 2020-2034 (USD Billion)
- 7.6.3. Biosurgery Market - Saudi Arabia
- 7.6.3.1. Saudi Arabia: Biosurgery Market, by Product, 2020-2034 (USD Billion)
- 7.6.3.2. Saudi Arabia: Biosurgery Market, by Application, 2020-2034 (USD Billion)
- 7.6.4. Biosurgery Market - UAE
- 7.6.4.1. UAE: Biosurgery Market, by Product, 2020-2034 (USD Billion)
- 7.6.4.2. UAE: Biosurgery Market, by Application, 2020-2034 (USD Billion)
- 7.6.5. Biosurgery Market - Israel
- 7.6.5.1. Israel: Biosurgery Market, by Product, 2020-2034 (USD Billion)
- 7.6.5.2. Israel: Biosurgery Market, by Application, 2020-2034 (USD Billion)
- 7.6.6. Biosurgery Market - South Africa
- 7.6.6.1. South Africa: Biosurgery Market, by Product, 2020-2034 (USD Billion)
- 7.6.6.2. South Africa: Biosurgery Market, by Application, 2020-2034 (USD Billion)
- 7.6.7. Biosurgery Market - Rest of Middle East & Africa
- 7.6.7.1. Rest of Middle East & Africa: Biosurgery Market, by Product, 2020-2034 (USD Billion)
- 7.6.7.2. Rest of Middle East & Africa: Biosurgery Market, by Application, 2020-2034 (USD Billion)
- 7.7. Biosurgery Market - Latin America
- 7.7.1. Latin America: Biosurgery Market, by Product, 2020-2034 (USD Billion)
- 7.7.2. Latin America: Biosurgery Market, by Application, 2020-2034 (USD Billion)
- 7.7.3. Biosurgery Market - Mexico
- 7.7.3.1. Mexico: Biosurgery Market, by Product, 2020-2034 (USD Billion)
- 7.7.3.2. Mexico: Biosurgery Market, by Application, 2020-2034 (USD Billion)
- 7.7.4. Biosurgery Market - Brazil
- 7.7.4.1. Brazil: Biosurgery Market, by Product, 2020-2034 (USD Billion)
- 7.7.4.2. Brazil: Biosurgery Market, by Application, 2020-2034 (USD Billion)
- 7.7.5. Biosurgery Market - Argentina
- 7.7.5.1. Argentina: Biosurgery Market, by Product, 2020-2034 (USD Billion)
- 7.7.5.2. Argentina: Biosurgery Market, by Application, 2020-2034 (USD Billion)
- 7.7.6. Biosurgery Market - Rest of Latin America
- 7.7.6.1. Rest of Latin America: Biosurgery Market, by Product, 2020-2034 (USD Billion)
- 7.7.6.2. Rest of Latin America: Biosurgery Market, by Application, 2020-2034 (USD Billion)
8. Competitive Landscape
- 8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
- 8.2. Partnerships/Collaborations/Agreements/Exhibitions
9. Company Profiles
- 9.1. Artivion, Inc.
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
- 9.2. Aroa Biosurgery
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
- 9.3. B. Braun SE
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
- 9.4. Baxter
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
- 9.5. BD
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
- 9.6. INTEGRA LIFESCIENCES
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
- 9.7. Johnson & Johnson Services, Inc.
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
- 9.8. Medtronic
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
- 9.9. Sanofi
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development
- 9.10. Pfizer Inc.
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Benchmarking
- 9.10.4. Recent Development
- 9.11. Stryker
- 9.11.1. Company Overview
- 9.11.2. Financial Performance
- 9.11.3. Product Benchmarking
- 9.11.4. Recent Development
